SecBot SecBot
Insider Cluster (2 insiders) ·Filed Apr 8, 2026

WHWK

Whitehawk Therapeutics, Inc.
BEARISH
Impact 6/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $386K total
Actionable Insight ▼ Bearish

Traders should monitor for further insider selling, especially from the CEO or other C-suite executives. A 0.2% net insider sell in a small-cap biotech like WHWK is notable and may signal reduced confidence in near-term prospects, particularly if not part of a pre-arranged plan.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
WHWK ▲ +13.24% at T+60d
SHORT call ✗ call lost -13.24% · α vs SPY -2.46% · entry $3.55 → $4.02
Entry = T+0 close
Apr 8, 2026
via day close
T+1d
-4.51%
call +4.51% · α +4.45%
$3.39
settled 7mo ago
T+5d
+19.15%
call -19.15% · α -15.97%
$4.23
settled 7mo ago
T+20d
+16.90%
call -16.90% · α -9.33%
$4.15
settled 6mo ago
T+60d
+13.24%
call -13.24% · α -2.46%
$4.02
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two corporate insiders at Whitehawk Therapeutics, including CEO David James Lennon, sold shares in open-market transactions over a 6-day period, totaling $386,000 in value. The CEO sold $49,000 worth of stock, while another insider, Bryan Ball, sold $337,000 across multiple trades, including a large sale just days before the cluster window closed.

Key Financial Metrics

Direction
selling
Total Value
$386.0K
Insiders
2

Key Facts

  • Insider trading cluster involves two individuals: CEO David James Lennon and Bryan Ball.
  • Total value of sales: $386,000 in open-market transactions over 7 days.
  • CEO David James Lennon sold 14,500 shares at $3.38, totaling $49,010.
  • Bryan Ball sold 175,445 shares in multiple transactions totaling $628,984.62, with $337K of that occurring within the cluster window.
  • All transactions were open-market sales (code S), indicating direct selling pressure from insiders.

Financial Impact

$386,000 in insider sales over 7 days, representing approximately 0.2% of the company's $189M market cap.

insider ownershipinvestor sentimentstock supply

Risk Factors

  • Perception of insider lack of confidence, especially given CEO participation in the selling.
  • Potential for downward price pressure if selling continues or becomes public in financial media.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-WHWK-1776297565843
10 reports for WHWK
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 5 of 5 best @ T+20▲ +17.65%May 13, 2026
Filters
Rows
Reports for WHWK — sortable, filterable
TypeNow
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$4.11 $4.07▼ −0.97%▼ −0.53%$3.18 (−22.63%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 3/10
$4.70 $4.76▲ +1.28%▲ +0.67%$3.18 (−32.34%)
Jun 10, 2026
19w ago
EFFECT
BEARISH ★ 6/10
$4.02 $4.06▼ −0.99%▲ +0.70%$3.18 (+20.90%)
May 29, 2026
21w ago
S-3
BEARISH ★ 6/10
$4.49 $4.18▲ +6.90%▲ +7.06%$3.18 (+29.18%)
May 13, 2026
23w ago
8-K
BEARISH ★ 8/10
$4.93 $5.10▼ −3.45%▼ −2.67%$3.18 (+35.50%)
May 7, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$3.94 $3.97▲ +0.76%▼ −0.07%$3.18 (−19.29%)
Apr 8, 2026
28w ago
Insider Cluster
BEARISH ★ 7/10
$3.55 $3.39▲ +4.51%▲ +4.45%$3.18 (+10.42%)
Apr 8, 2026
28w ago
Insider Cluster
BEARISH ★ 6/10
$3.55 $3.39▲ +4.51%▲ +4.45%$3.18 (+10.42%)
Apr 8, 2026
28w ago
Insider Cluster
BEARISH ★ 7/10
$3.55 $3.39▲ +4.51%▲ +4.45%$3.18 (+10.42%)
Mar 12, 2026
32w ago
8-K
NEUTRAL ★ 4/10
$3.90 $3.91▲ +0.26%▲ +0.85%$3.18 (−18.46%)
Showing 10 of 10

US Market Status

Market Open — Closes in 5h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026